# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-24-006850
Filing Date
2024-02-26
Accepted
2024-02-26 16:06:55
Documents
162
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | mrk-20231231.htm iXBRL | 10-K | 5080817
2 | EX-10.7 FORM OF STOCK OPTION TERMS FOR 2017 ANNUAL NON-QUALIFIED OPTION GRANTS | ex107-2017annualnqsotermsc.htm | EX-10.7 | 34962
3 | EX-10.8 FORM OF STOCK OPTION TERMS FOR 2019 ANNUAL NON-QUALIFIED OPTION GRANTS | ex108-2019annualnqsotermsa.htm | EX-10.8 | 43881
4 | EX-10.13 MERCK & CO., INC. U.S. SEPARATION BENEFITS PLAN | ex1013-plansepmrk2019.htm | EX-10.13 | 503445
5 | EX-10.21 2020 ANNUAL NQSO TERMS AND CONDITIONS | ex1021-2020annualnqsoterms.htm | EX-10.21 | 41031
6 | EX-10.22 2020 ANNUAL RSU TERMS AND CONDITIONS | ex1022-2020annualrsutermsa.htm | EX-10.22 | 41590
7 | EX-10.23 2021 ANNUAL PSU TERMS AND CONDITIONS | ex1023-2021annualpsuterms.htm | EX-10.23 | 80592
8 | EX-10.24 2021 RSU GRANT TERMS UNDER MERCK CO INC 2019 ISP | ex1024-2021specialretentio.htm | EX-10.24 | 40187
9 | EX-10.25 2022 ANNUAL RSU TERMS AND CONDITIONS | ex1025-2022annualrsutermsa.htm | EX-10.25 | 320481
10 | EX-10.26 2022 ANNUAL PSU TERMS AND CONDITIONS AUGUST (GUINDO) | ex1026-2022annualpsutermsa.htm | EX-10.26 | 196248
11 | EX-10.27 2023 ANNUAL NQSO TERMS AND CONDITIONS | ex1027-2023annualnqsoterms.htm | EX-10.27 | 152265
12 | EX-10.28 2022 ANNUAL PSU TERMS AND CONDITIONS | ex1028-2022annualpsutermsa.htm | EX-10.28 | 100770
13 | EX-10.29 2023 ANNUAL PSU TERMS AND CONDITIONS | ex1029-2023annualpsutermsa.htm | EX-10.29 | 189567
14 | EX-10.30 OFFER LETTER (GUINDO) | ex1030-mrkchirfiguindooffe.htm | EX-10.30 | 47370
15 | EX-21 SUBSIDIARY LIST | ex21-subsidiarylistasof123.htm | EX-21 | 312516
16 | EX-23 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | ex23-consentofindependentr.htm | EX-23 | 2323
17 | EX-24.1 POWER OF ATTORNEY | ex241-powerofattorney.htm | EX-24.1 | 14715
18 | EX-24.2 CERTIFICATION OF BOARD RESOLUTION | ex242-certificationofboard.htm | EX-24.2 | 6759
19 | EX-31.1 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CEO | ex311-rule13ax14a15dx14ace.htm | EX-31.1 | 8068
20 | EX-31.2 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CFO | ex312-rule13ax14a15dx14ace.htm | EX-31.2 | 8103
21 | EX-32.1 SECTION 1350 CERTIFICATION OF CEO | ex321-section1350certifica.htm | EX-32.1 | 4057
22 | EX-32.2 SECTION 1350 CERTIFICATION OF CFO | ex322-section1350certifica.htm | EX-32.2 | 3662
23 | EX-97 MERCK RECOUPMENT POLICY | ex97-merckrecoupmentpolicy.htm | EX-97 | 19562
29 |  | mrk-20231231_g1.jpg | GRAPHIC | 137767
30 |  | mrk-20231231_g2.jpg | GRAPHIC | 82583
31 |  | mrk-20231231_g3.jpg | GRAPHIC | 28277
32 |  | mrk-20231231_g4.jpg | GRAPHIC | 24891
33 |  | mrk-20231231_g5.jpg | GRAPHIC | 24379
34 |  | mrk-20231231_g6.jpg | GRAPHIC | 25771
35 |  | mrk-20231231_g7.gif | GRAPHIC | 5605
36 |  | mrk-20231231_g8.jpg | GRAPHIC | 31485
37 |  | mrk-20231231_g9.jpg | GRAPHIC | 17845
| Complete submission text file | 0001628280-24-006850.txt |  | 29075527

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
24 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | mrk-20231231.xsd | EX-101.SCH | 126440
25 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | mrk-20231231_cal.xml | EX-101.CAL | 192302
26 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | mrk-20231231_def.xml | EX-101.DEF | 800944
27 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | mrk-20231231_lab.xml | EX-101.LAB | 1659744
28 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | mrk-20231231_pre.xml | EX-101.PRE | 1172170
164 | EXTRACTED XBRL INSTANCE DOCUMENT | mrk-20231231_htm.xml | XML | 5809835

Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-06571 | Film No.: 24678716
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)